BRAF V600E mutations are not an oncogenic driver of solitary xanthogranuloma and reticulohistiocytoma: Testing may be useful in screening for Erdheim-Chester disease

Overview

cited authors

Hoyt, Brian S.; Yan, Shaofeng; Linos, Konstantinos D.; Momtahen, Shabnam; Sriharan, Aravindhan; Tran, Tien-Anh N.; Tsongalis, Gregory J.; O'Meara, Rebecca R.; Green, Donald C.; LeBlanc, Robert E.

authors

Tran, Tien-Anh Nguyen, MD

Publication Date

December 1, 2019

webpage

Web of Science

published in

EXPERIMENTAL AND MOLECULAR PATHOLOGY Journal

Research

keywords

BRAF
Erdheim-Chester disease
Histiocytosis
Langerhans cell
Reticulohistiocytoma
Xanthogranuloma

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.